Diabetes treatments

Featured Market Report: Type 2 Diabetes – Epidemiology Forecast to 2024

pharmafile | November 16, 2015 | Feature | Manufacturing and Production, Research and Development |  diabetes, market reports 

Diabetes is one of the most common non-communicable diseases worldwide and is an escalating public health problem globally, with an estimated 387 million people living with diabetes worldwide. At least 90% of all diabetes cases are type 2.

This report has been created by Masters- and PhD-level epidemiologists, and provides invaluable analysis of the risk factors, comorbidities, and global trends for type 2 diabetes in nine major markets (US, France, Germany, Italy, Spain, UK, Japan, China, and India).

It includes a 10-year epidemiological forecast of the one-year prevalent cases of type 2 diabetes, segmented by sex, age (in five-year increments beginning at 20 years and ending at =85 years), and comorbidities in these markets.

The information included in the 70-page report from respected and leading analyst GlobalData will enable the reader to:

Advertisement
  • Shape their global strategy by understanding the trends shaping and driving the global T2D market.
  • Accurately quantify patient populations in the global T2D market to improve product design, pricing, and launch plans.
  • Organise sales and marketing efforts by identifying the sex and age groups that present the best opportunities for T2D therapeutics in each of the markets covered.

For a full summary, and to find out how to purchase the full report, click here.

Related Content

MetP Pharma releases positive data on intranasal semaglutide administration

MetP Pharma has released new data highlighting the advantages of its MetP technology in delivering …

handshake_2

AOTI diabetic foot care therapy to be used by NHS

Effective from September 2025, AOTI’s Topical Wound Oxygen (TWO2) therapy has been awarded inclusion in …

Recce Pharmaceuticals reports positive phase 2 data for skin infection drug

Recce Pharmaceuticals have announced positive patient data from its phase 2 clinical trial into RECCE …

The Gateway to Local Adoption Series

Latest content